Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN,...
Transcript of Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN,...
![Page 1: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/1.jpg)
Clinical Case Studies (Insulin Delivery)
Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTCABQ Health Partners, Albuquerque, New Mexico
![Page 2: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/2.jpg)
InsulinDelivery:Pumps,Pens&More
ClinicalCaseStudiesBy
DonnaTomky,MSN,RN,BC-ANP,CDE,FAADE,CDTCABQHealthPartners
DeptofEndocrinology&DiabetesAlbuquerque,NM
![Page 3: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/3.jpg)
Disclosures
• Consultant:BectonDickinson,Voluntis
• Speaker: ProgramManagementServices,Inc.
![Page 4: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/4.jpg)
CaseStudyforInsulinPens• 71yo NativeAmericanfemalewithT2DMx8yrs.Lives
withdaughter&9yo grandson• Novolog(flexpen)5-10unitsbeforemeals,Lantus 25
unitsatbedtime• A1Cof9.3%,Wt147lbs,BMI28• DifficultydrawingupLantuswithoutglasses&gives
insulininjectionat45degreeanglewithinsulinsyringe(doesn’tknowaboutLantuspen-likesNovologpen)
• Localizedfibrosis&ecchymosis bilaterallowerabdomen
• Checkingbloodsugar1-2timesaday– glucoserangefrom86-465mg/dl
![Page 5: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/5.jpg)
Whatisyourassessmentofproblems?(Groupactivity)
• Diabetesuncontrolled• PossiblynotalwaysgettingprescribedLantusdosebecauseofpoorvision(20-80%ptsmakeerrors1)
• Notrotatinginjectionsites• Possiblygettingintra-dermalinjections• Non-adherence(estimates30-60%)1-3
1.Meichenbaum D,TurkDC.FacilitatingTreatmentAdherence:APractitioner'sGuidebook. NewYork:PlenumPublishingCorp;1987.2.Buckalew LW,Sallos RE.Patientcomplianceandmedicationperception.JClin Psychol. 1986;42:49-53.Sackett DL,SnowJC.Themagnitudeofcomplianceandnoncompliance.In:HaynesNRB,TaylorDW,Sackett DL,eds.3.ComplianceinHealthcare. Baltimore:JohnsHopkinsUniversityPress;1979:11-22.
![Page 6: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/6.jpg)
PossibleSolutions(GroupActivity)• SwitchtoLantus solostar
pen• Reviewproperinjection
techniqueandrotationofsites– “Airshot”orprimingofpen– Dialingupdose– Adequatestrength&
dexterityforoperatingdosingbutton
– Pushdosingbuttondown(Notdialingdown)
– Assessforfibrosis• StepupSBMGac&hs• Use4or5mmpenneedle
![Page 7: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/7.jpg)
Applications-PumpCaseStudy
1. Choosingtherightpumpforeachpatient
2. Determiningtotaldailyinsulindoses3. Determiningandadjustingbasaldoses
4. Determiningbolusdoses
5. Calculatingtheinsulin–carbohydrateratio(ICR)6. Calculatingtheinsulinsensitivityfactor(ISF)
7. Calculatinginsulinonboard(IOB)andavoidingstacking
![Page 8: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/8.jpg)
Application– PumpCaseStudy
• Janetis36-yofemalew/T1DMx3yrs
• Patienthascollegedegree,stayathomemom&extremelybusylifewith4children– 5yo son&with3yotriplets.Patientstruggleswithweight
![Page 9: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/9.jpg)
Janet– PumpCaseStudy• Currentinsulindoses:– Lantusinsulin- 12unitsBID,HumalogKwikpenadjusteddoses1unitforevery12gofcarbohydrateandcorrectionfactorIunitforevery25above150
• MonitoringglucosewithaOneTouchmeter5-8timesaday.Averageglucose158mg/dl,rangingfrom55-398mg/dL
• A1C- 7.1%-8.6%;Wt-161,Ht-59”(4’11”)BMI-31.8
![Page 10: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/10.jpg)
WhichpumpisbestforJanet?
1. Medtronic530G2. Omni-Pod3. TandemT-SlimG44. AnimasVibe5. Accuchek Combo
•
ConsumerGuide2015.DiabetesForecast,Mar/Apr2015
![Page 11: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/11.jpg)
WhichpumpisbestforJanet?
PUMPBRAND1. Medtronic530G
2. Omni-Pod
3. TandemT-SlimG4
4. AnimasVibe
5. Accuchek Combo
ONEUNIQUEFEATURE• LinkstoEnlite CGMsensor
• Patchpump– notubing
• ColortouchscreenandlinkstoDexCom G4CGM
• OnetouchmeterremotecontrolLinkstoDexCom G4CGM
• Accuchek meterremotecontrol
![Page 12: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/12.jpg)
WhichpumpisbestforJanet?
PUMPBRAND1. Medtronic530G2. Omni-Pod3. TandemT-Slim4. Animas5. AsanteSnap6. Accuchek Combo
ONEUNIQUEFEATURE• LinkstoEnlite CGMsensor• Patchpump– notubing• Colortouchscreen• LinkstoDexCom G4CGMsensor• 300unitprefilledcartridge• Accuchek meterremotecontrol
ANSWER:TheonethatfitsJanet’slifestyleandneeds
![Page 13: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/13.jpg)
StartbydeterminingJanet’sTotalDailyDose(TDD)?
• TDDissumofbasal,bolus&correctioninsulin• Majorfactorforcontrollingglucose-A1c• CloselyestimatesBolusCalculatorsettings• Methodsforcalculating:
1. UseReducedInjectionDoseapproach
2. UseWeightBaseapproach
3. Combinationofboth
4. ConversionfromMDIDoses
![Page 14: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/14.jpg)
DeterminingJanet’sPumpTotalDailyDose(TDD)?
Reduce Injection Dose (RD)• Based on daily Injection Doses
(basal, bolus, CF)• Injection Dose x 0.75 (75-80%)
=RD
Weight Dose (WD)• Based on Weight• Lb x 0.23 units =Wt Dose • or kg x 0.50 u= Wt Dose
Initial Pump TDD
Take average of Reduced and Weight Dose
(Reduced Dose + Weight Dose) ÷2 = Pump TDD
BodeB,Kyllo J,KaufmanK.MedtronicPumpProtocol:AGuidetoInsulin PumpTherapyInitiation
![Page 15: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/15.jpg)
WhatisJanet’sTotalDailyDose(TDD)?
ReduceInjectionDose(RD)• InjectionDosex0.75=RD• Janet’sTDD=24uLantus +
7uTIDofHumalog=45ux0.75=33.75u/day(TDD)
WeightDose(WD)• Lbx0.23u=WDorkgx0.50
u=WD• 161(wt-lbs)x0.23u=37• (161/2.2)=73kgx0.5u=36.5
Initial Pump TDD (33.75 u/day +37 u/day)÷2 = 35 u/day
BodeB,Kyllo J,KaufmanK.MedtronicPumpProtocol:AGuidetoInsulinPumpTherapyInitiation
![Page 16: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/16.jpg)
ConsiderationsforBasalInsulin
• TotalBasalDose(TBD)=U/dachievestargetBGforfasting(>4hrpp),controlsearlyam,dawnphenomenon,w/ohypoglycemiaifmealmissed
• SingleorMultipleBasals– Besttostartwithsinglebasal– Considermultiplebasals fordawnphenomenonor
physicallyactiveduringdayorifuniquepatternidentified• Basalinsulinaccounts~50%ofTDD
– Adults– 40-50%– PubertytoAdult—30-40%– Pre-pubertytoPuberty—20-40%
![Page 17: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/17.jpg)
Determining&AdjustingBasalDoses
• Method1:Basalrate=TDDx40-50%– DailyBasalDose÷24=u/h(1conventional)
• Method2:Basalrate=TDDx0.48÷24(2APP)• AdjustbasalratesbasedonSMBGorCGMpatterns
• Nighttimebasalratesshouldbefine-tunedbeforedaytimebasalrates
2WalshJetal.GuidelinesforOptimalBolusCalculatorSettingsinAdults.JofDiab Science&Technology.Vol 5,1,Jan2011.
1 BodeB,Kyllo J,KaufmanK.MedtronicPumpProtocol:AGuidetoInsulinPumpTherapyInitiation
![Page 18: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/18.jpg)
WhatisJanet’sBasalRate• Method1:Basalrate/hr=(TDDx
0.5)÷24hrs (1conventional)– 35unitsx0.5÷ 24hrs– 17.5units÷ 24hrs =0.729or0.75u/h
• Method2:Basalrate=TDDx0.48÷24 (2APP)– 35unitsx0.48÷ 24hrs– 16.8÷ 24hrs =0.7u/h
1 BodeB,Kyllo J,KaufmanK.MedtronicPumpProtocol:AGuidetoInsulinPumpTherapyInitiation2WalshJetal.GuidelinesforOptimalBolusCalculatorSettingsinAdults.JofDiab Science&Technology.Vol 5,1,Jan2011.
![Page 19: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/19.jpg)
DeterminingBolusI:CDoses
• Insulin-to-CarbohydrateRatio(ICR)– #ofunitsthatreturns
theBG+/-20%ofpre-mealBGin2-4hrs
– 1unitofinsulincovers#gramsofcarbohydrates
– Patientsmayneeddifferentratiosthroughouttheday
![Page 20: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/20.jpg)
DeterminingBolusI:CDoses
• Methodsforcalculating– ConvertfromMDIregime(if
wellcontrolled)– EstimateDailyCarbIntake1
• TotalCarbGrams÷ TotalDailyBolus(~50%TDD)=ICR
– 450(500)Rule(Conventional)1• 450(500)÷ PumpTDD=ICR
– ICR=[2.6xWt(lb)]÷ TDD(APP)2
1BodeB,Kyllo J,KaufmanK.MedtronicPumpProtocol:AGuidetoInsulinPumpTherapyInitiation2WalshJetal.GuidelinesforInsulinDosinginCSIIusingnewformulasfromretrospectivestudyofindividualsw/optimalglucoselevels.JofDiab Sci &Tech.Vol 4,Sept2010
![Page 21: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/21.jpg)
WhatisJanet’sICR• Method1:
450(500)Rule(Conventional)1
– 450(500)÷ PumpTDD=ICR• 450÷ 35(TDD)=12.8=1:13• 500÷ 35(TDD)=14.3=1:14
• Method2:ICR=[2.6xWt(lb)]÷ TDD(APP)2- ICR=[2.6x161lbs]÷ 35- ICR=418.6÷ 35- ICR=11.96=1:12
• Janet’sPreviousICR=1:121BodeB,Kyllo J,KaufmanK.MedtronicPumpProtocol:AGuidetoInsulinPumpTherapyInitiation2WalshJetal.GuidelinesforInsulinDosinginCSIIusingnewformulasfromretrospectivestudyofindividualsw/optimalglucoselevels.JofDiab Sci &Tech.Vol 4,Sept2010
![Page 22: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/22.jpg)
CarbohydrateCountingApproaches
• Basic Carb Counting– Consistent amounts of carb at meals &
snacks– Some find it difficult to be consistent
• Advanced Carb Counting– Insulin dose is adjusted to match carb intake– Accuracy of insulin dose depends on ability to
estimate/measure food portions and knowledge of amount of carbs/portion
• WAG Carb Counting –commonly used
![Page 23: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/23.jpg)
Notasimpletask…
![Page 24: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/24.jpg)
CarbCountingTools
“PumpingInsulin”byWalshJ&RobertsR
![Page 25: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/25.jpg)
ThreeTypeofBolusInsulin
RegularorNow§ Takeimmediately—formostmeals
Combo/Dualwave§ Somenow,somelater–beanburrito,
somepastas,pizza,Symlin
Extended/Squarewave§ Extendedovertime-- gastroparesis
%In
sulin
Time(hours)012345678
01
0203
04
05
06070
809
01
00%
![Page 26: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/26.jpg)
DeterminingBolusCorrectionFactor(CorrF)orInsulinSensitivityFactor(ISF)
• CorrectionFactor(CorrF)orInsulinSensitivityFactor(ISF)– Usedtocalculate
correctionbolusamountstoreturnBG+/-20%oftargetBGin2-4hrs
– Thenumberofmg/dlthat1unitofinsulinlowersBG
– InsulinsubtractedfromfoodboluswhenBG<target
![Page 27: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/27.jpg)
DeterminingBolusCorrF Doses
• Methods– 1700Rule1
• 1700÷PumpTDD=ISF
– 2000Rule(frequenthypoglycemia) 2• 2000÷ PumpTDD=ISF
– 1960Rule(nearnormal-144mg/dl~BG)3• 1960÷ PumpTDD=ISF
1DavidsonPetal.AnalysisofGuidelinesforBasal-Bolusinsulindosing.EndocrinePractice.Dec20082BodeB,Kyllo J,KaufmanK.MedtronicPumpProtocol:AGuidetoInsulinPumpTherapyInitiation3WalshJetal.GuidelinesforInsulinDosinginCSIIusingnewformulasfromretrospectivestudyofindividualsw/optimalglucoselevels.JofDiab Sci &Tech.Sept2010
![Page 28: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/28.jpg)
WhatisJanet’sCorrF orISF?• Method1:1700Rule1
– ISF=1700÷35àISF=49
• Method2:2000Rule(frequenthypoglycemia) 2– ISF=2000÷ 35àISF=57
• Method3:1960Rule(nearnormal-144mg/dl~BG)3
• ISF=1960÷ 35à ISF=56
• Janet’sPreviousISF=251BodeB,Kyllo J,KaufmanK.MedtronicPumpProtocol:AGuidetoInsulinPumpTherapyInitiation2WalshJetal.GuidelinesforInsulinDosinginCSIIusingnewformulasfromretropective studyofindividualsw/optimalglucoselevels.JofDiab Sci &Tech.Vol 4,Sept2010
![Page 29: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/29.jpg)
DeterminingTargetBloodGlucose• CorrectionBolusandTargetBloodGlucoseorRange– TheBGorrangeofglucosevaluestheboluscalculatorusestodetermineifcorrectiondoseisneeded
BodeB,Kyllo J,KaufmanK.MedtronicPumpProtocol:AGuidetoInsulinPumpTherapyInitiation
![Page 30: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/30.jpg)
DeterminingBolusActiveInsulin• ActiveInsulinTime– Thelengthoftimethecalculatortracksactiveinsulinafterbolusisgiven
– Avoidsstackingofinsulin– Considerinsulinaction
• ClinicalConsiderations– Adults:4-5hours– Children:3-4hours– Pregnancy:3-4hours
BodeB,Kyllo J,KaufmanK.MedtronicPumpProtocol:AGuidetoInsulinPumpTherapyInitiation
![Page 31: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/31.jpg)
WhatshouldJanet’sTargetBG&ActiveInsulin?
• Historyofhypoglycemiaunawareness• Consider110-130mg/dl–night
time
• Consider100-120mg/dl– daytime
• Janet’sPreviousISF=25• NewISForCF=49-57=50
• ActiveInsulinTime=4hrs1BodeB,Kyllo J,KaufmanK.MedtronicPumpProtocol:AGuidetoInsulinPumpTherapyInitiation2WalshJetal.GuidelinesforInsulinDosinginCSIIusingnewformulasfromretropective studyofindividualsw/optimalglucoselevels.JofDiab Sci &Tech.Vol 4,Sept2010
![Page 32: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/32.jpg)
BasalRateAdjustments
• Overnightvs DaytimeBasalRates– Lastdoseofbolusinsulin4hrspriortotest– Assessovernightcontrolrise/fallpatterns– Assessdaytimecontrolbyskippingmeal-time– Goal- BGstablewithintarget(+/-30mg/dl)– IfBGrise/fall>30mg/dlà adjustrateá 10-20%~2-3hrsbefore
– IfBGdropsbelow70mg/dlà treatàâ 10-20%
![Page 33: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/33.jpg)
BolusAdjustments
• Insulin-to-CarbRatios(ICR)– Goal:2hppBGisbetween30-60mg/dlhigherthanpre-mealBG• Bolusesmissedorlate?• Accuratecarb counting?• Adheretopumpcalculatoradvise?
• InsulinSensitivityFactororCorrectionBolus– Goal:Post-correction,2-hrBG~halfwaytotarget&attargetby4hrs
![Page 34: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/34.jpg)
TwoWeekGlucoseMeterSummary
FollowupData– Meter
![Page 35: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/35.jpg)
StatisticsAverage Glucose 146 mg/dL
Sensor Usage 7 of 7 DaysCalibrations / day 3.3Standard Deviation ± 43 mg/dL
61 % High
39 % Target
1 % Low
Target Range 80 - 130 mg/dLNighttime 10:00 PM - 6:00 AM
CGMData– Refinement&Safety
![Page 36: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/36.jpg)
ConsiderPumpSafety&EnhancementFeatures
• MaximumBolusdose• MaximumBasalrate• Lowreservoiralert• Sitechangealert• Settingalert2hrs aftersitechangetocheckBG• Auto-Off• CGMalerts• Customreminders
![Page 37: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/37.jpg)
Onemorethought&casestudy…
![Page 38: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/38.jpg)
• ReferredforFrequentseverehypoglycemicevents(>1x/wk duringday)
• SMBG5-6xperday• A1Crange7.3-9.0%• Insulinregime:Lantus10
unitsqam;NovologonlyCF- 1unitforBG>300
• Wt - 100lbs;Ht – 5’1”• Cr-0.83mg/dl;GFR-83• Nonephropathy
• Smokerw/frequentURI&pneumonias
• Significantstresswithworkandfamily– onantidepressant
• Endocrinologyworkupforadrenalinsufficiency,&celiacisnegative
• Hypothyroidismstable
MeetTJ… 48yo Fw/T1DMx45yrs
![Page 39: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/39.jpg)
TJ…continued• Endocrinologistchangedinsulinregime– SplitLantusto6unitsqAMand2unitsqPM– TriedToujeobuthypoglycemiawasworse– PatientrestartedLantus7unitsqAM
• StartedCGMwhichhelpedreduceseverehypoglycemicepisodes
• HadaseverehypoglycemicepisodewhilewearingCGM,butalsodiagnosedwithpneumoniaintheER
• ReferredtoNP/CDEforpumppreparation
![Page 40: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/40.jpg)
TJsCGMRecordsHighBGs
![Page 41: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/41.jpg)
• What does the A1c level tell you? 7.3% indicates reasonable control
• What does the history tell you? Erratic BGs and multiple severe hypoglycemic episodes. Work up for other endocrinopathies negative, except for hypothyroidism which is stable. Has tried several basal insulin adjustments and uses bolus insulin sparingly
• What do the glucose records tell you?– Identify the problem – Severe hypoglycemia disabling
patient, on medical leave from work and not driving.– Determine the pattern/trend – Day time low blood
glucose and night time high blood glucose; not checking BG before dosing insulin.
– Identify the cause(s) – Not enough information based on above
• What’s your approach? Ask more questions about behaviors and do focused exam
Putting it all together?
![Page 42: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/42.jpg)
BGResults
WhatEffectsBloodGlucoseResults?
Physical Activity•Change in type,
frequency, duration, or intensity
Eating· Effect of type, amount, frequency, timing of food and alcohol on glucose,
special situations
MedicationChange in timing, amount, delivery, dose accuracy, lipodystrophy, polypharmacy
Acute Problems Illness, stress or acute
complications, co-morbid conditions
Complications or RisksPhysical infirmities, gastroparesis, visual
impairment, renal function, pregnancy
Coping SkillsStress, change in
coping skills, depression, cognition,
social isolation Self-CareBehaviorsAre
Important!
![Page 43: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/43.jpg)
WhataboutTJ’sSelf-Care?
• Lipohypertrophy—usingforallinjections(48-65%prevalence)1,2
• Using8mmpenneedle• Usinginsulinpenbuthasneverknownaboutgivingan“airshot”
• FocusedExam…
1.BlancoMetal.Prevalence&riskfactorsoflipohypertrophy ininsulin injectingpts w/dm.DiabetesMetab.2013.2.Ji Letal.Lipohypertrophy –prevalence,&riskfactors&clinical characteristics ofinsulin-requiringpatientsinChina.AbstractEASDVienna2014.
![Page 44: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/44.jpg)
NextStepsforTJ…• Identify the cause(s)—
– Lipodystrophy injection sites causes insulin absorption variability
– Possible IM injections with 8 mm needles– Incorrect Injection technique maybe causing dosing
errors– Dosing insulin and treating low BG without verifying
CBG• What’s your approach?
– Options: 1)Avoidlipohypertrophy areas;2)Changeto4mmpenneedle;3)Correctinjectiontechnique;4)Trydegludec insulin;5)Use½unitdosingpenforNovolog;5)PrepareforCSII
– Shared Decision: Action Plan: All of the above agreed upon
![Page 45: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/45.jpg)
InSummary• Patientselectionandadherenceiscritical• Initiationandtraining• PatientcenteredàIndividualizesettings• Problemsolvingskills/behaviorscriticalforsuccessfulpumpexperience
• Accuratedataiscriticalformakingdecisions• Focusedexamofsitesateveryvisitoratleastannually
• Planandprovideongoingevaluationandsupportbyentireteam
![Page 46: Clinical Case Studies (Insulin Delivery)Clinical Case Studies (Insulin Delivery) Donna Tomky, MSN, RN, C-NP, CDE, FAADE, CDTC ABQ Health Partners, Albuquerque, New Mexico](https://reader030.fdocuments.us/reader030/viewer/2022011901/5f08893c7e708231d4227ebb/html5/thumbnails/46.jpg)
Muchas Gracias– Questions?